Table 1. Demographic and clinical characteristics of the study population.
Characteristics | N = 130 n (%) |
---|---|
Age (years) (median) | 83.0 (80.0-87.0) |
Male sex | 67 (51.5) |
BMI (median) | 25.3 (22.5-29.4) |
Clinical presentation | |
Syncope | 38 (29.2) |
Angina pectoris | 27 (20.8) |
HF, NYHA functional class | |
II | 6 (4.8) |
III | 70 (53.8) |
IV | 54 (41.5) |
Systemic arterial hypertension | 94 (72.3) |
Diabetes mellitus | 48 (36.9) |
Coronary arterial disease | 70 (53.8) |
Previous AMI | 15 (11.5) |
Previous MRS | 30 (23.1) |
Previous PCI | 42 (32.3) |
Previous stroke | 7 (5.4) |
Peripheral vascular disease | 31 (23.8) |
COPD | 12 (9.2) |
Chronic kidney disease* | 101 (77.7) |
Pulmonary arterial hypertension | 40 (30.8) |
Previous pacemaker | 25 (19.2) |
STS mortality (%) | 8.6 (4.8-19.3) |
STS morbidity (%) | 34.6 (24.8-63.1) |
Anemia | 83 (63.8) |
Atrial fibrillation | 17 (13.1) |
LV dysfunction (LVEF < 50%) | 33 (25.4) |
BMI: body mass index; HF: heart failure; NYHA: New York Heart Association; AMI: acute myocardial infarction; MRS: myocardial revascularization surgery; PCI: percutaneous coronary intervention; COPD: chronic obstructive pulmonary disease; STS: Surgeons Thoracic Society; LV: left ventricle LVEF: LV ejection fraction.
Glomerular filtration rate estimated by the Cockcroft-Gault formula < 60 mL/min.